TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
AKBA

Akebia Therapeutics, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

0.8962$ -2.5% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Akebia Therapeutics, Inc. (AKBA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 350 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet AKBA
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
169 300 259 337 339 364 443 414 404 997 891 824 795 771 788 745 676 644 629 612 602 529 535 522 436 356 277 254 235 242 225 220 207 221 310 346 364 377 363 350
165 296 255 332 334 358 437 407 398 468 347 316 299 310 341 449 391 371 365 331 330 271 303 304 238 185 121 118 110 118 113 112 100 114 204 235 258 253 243 230
66 187 87 125 90 70 158 164 162 105 63 87 123 148 116 245 169 229 253 247 207 150 175 144 145 90 57 54 47 43 42 39 34 52 113 137 166 185 163 156
161 260 252 321 330 318 393 402 390 322 168 137 146 148 116 295 269 269 273 247 207 150 175 144 145 90 57 54 47 43 42 39 34 52 113 137 166 185 163 156
34 34 34 – 0.3 34 36 0.1 0.7 17 48 29 30 39 105 39 24 29 35 35 50 52 65 82 23 40 18 20 23 39 27 30 32 34 62 73 66 47 63 54
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 114 115 122 116 116 112 105 88 61 45 38 34 37 39 36 40 22 21 21 18 16 26 24 20 16 20 17 19 16 13 13
2.7 2.6 2.9 2.9 3.4 3.6 3.7 3.7 3.8 8.0 9.5 11 13 10 9.9 9.4 8.8 8.6 8.2 32 7.2 6.8 39 38 36 5.2 4.8 4.4 – – – – – – – – – – – –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55 55 55 55 55 55 55 55 55 55 55 55 59 55 55 55 59 55 59 59 59 59 59 59 59 59 59 59 59 59 59
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 328 319 309 300 291 282 157 151 144 135 126 117 108 99 90 81 72 63 54 45 36 27 18 9.0 – – – – – – –
68 232 229 280 239 245 246 248 261 361 324 304 328 376 391 375 358 397 415 437 465 455 509 460 422 351 291 281 274 272 253 254 258 270 286 316 323 344 335 325
26 114 133 182 151 144 151 164 177 266 203 186 223 208 214 196 181 187 173 166 189 261 254 234 188 130 83 92 80 100 66 107 66 81 91 119 133 163 174 161
40 – 0.0 0.0 0.0 1.0 1.0 – – 15 4.7 4.8 4.9 5.0 5.1 5.2 5.3 5.3 5.4 5.6 5.7 102 103 103 70 37 29 29 13 22 5.1 7.2 7.5 9.7 5.5 5.6 4.9 3.5 12 25
8.5 2.0 15 10 8.7 7.0 18 4.8 13 43 15 19 64 39 54 29 40 41 31 42 29 34 19 25 20 18 13 12 9.0 15 12 10 13 15 13 12 10 21 8.4 9.4
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – 31 – – 77 78 78 79 99 97 97 97 1.8 – – – 34 27 19 35 17 30 38 38 39 47 47 48 48 36 25
101 68 31 57 100 119 197 166 143 636 566 519 468 395 396 370 318 248 214 175 137 74 26 62 14 5.2 -14 -27 -39 -31 -27 -34 -50 -49 25 29 42 33 27 25
-259 -297 -342 -363 -386 -374 -394 -428 -454 -514 -587 -645 -700 -794 -855 -1,031 -1,091 -1,178 -1,247 -1,330 -1,390 -1,463 -1,523 -1,493 -1,545 -1,557 -1,579 -1,595 -1,610 -1,609 -1,627 -1,636 -1,656 -1,678 -1,672 -1,672 -1,671 -1,684 -1,693 -1,702
38 39 39 41 47 49 49 57 57 117 117 118 119 119 128 137 143 145 154 161 174 176 180 190 184 184 185 187 188 190 205 210 210 219 242 271 274 265 267 270

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?